You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bevacizumab

Showing 51 - 75 of 1,284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Bevacizumab
  • +5 more
  • Pisa, Italia, Italy
    Francesca Vannini
Jan 4, 2023

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 23, 2022

Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2022

Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China

Recruiting
  • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
  • Benowa, Queensland, Australia
  • +7 more
Jan 30, 2023

Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

Not yet recruiting
  • Locally Advanced Colorectal Cancer
  • (no location specified)
Oct 18, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer Trial in United States

Recruiting
  • Combined Hepatocellular Carcinoma and Cholangiocarcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Auburn, California
  • +16 more
Aug 17, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Sep 15, 2022

Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • CapOx(Capecitabine+ Oxaliplatin)
  • +2 more
  • (no location specified)
Oct 18, 2022

Hepatocellular Carcinoma Trial in Tianjin (Sintilimab, Bevacizumab, Liver Protective Support Therapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 8, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Cervical Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Cisplatin)

Recruiting
  • Cervical Cancer
  • Miami, Florida
    University of Miami
Oct 1, 2022

NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Brain Neoplasms
  • bevacizumab
  • +2 more
  • (no location specified)
Dec 9, 2022

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Glioblastoma Multiforme Trial in Philadelphia (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Bevacizumab
  • Philadelphia, Pennsylvania
    (unnamed)
Aug 8, 2022

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • (no location specified)
Nov 10, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bevacizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • (no location specified)
Jul 28, 2022

Platinum-resistant Recurrent Ovarian Cancer Trial in Wuhan (Docetaxel for injection (Albumin-bound), Bevacizumab)

Recruiting
  • Platinum-resistant Recurrent Ovarian Cancer
  • Docetaxel for injection (Albumin-bound)
  • Bevacizumab
  • Wuhan, Hubei, China
    Tongji Hospital,Tongji Medical College of HUST
Oct 12, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Nov 21, 2022